- Home
- PLX vs CLAR Comparison
PLX vs CLAR Comparison
Compare PLX & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- CLAR
- Stock Information
- Founded
- PLX 1993
- CLAR 1957
- Country
- PLX Israel
- CLAR United States
- Employees
- PLX N/A
- CLAR N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- CLAR Recreational Games/Products/Toys
- Sector
- PLX Health Care
- CLAR Consumer Discretionary
- Exchange
- PLX Nasdaq
- CLAR Nasdaq
- Market Cap
- PLX 160.2M
- CLAR 173.0M
- IPO Year
- PLX 1998
- CLAR N/A
- Fundamental
- Price
- PLX $2.33
- CLAR $4.78
- Analyst Decision
- PLX
- CLAR Strong Buy
- Analyst Count
- PLX 0
- CLAR 3
- Target Price
- PLX N/A
- CLAR $6.33
- AVG Volume (30 Days)
- PLX 553.9K
- CLAR 162.3K
- Earning Date
- PLX 03-13-2025
- CLAR 03-06-2025
- Dividend Yield
- PLX N/A
- CLAR 2.10%
- EPS Growth
- PLX N/A
- CLAR N/A
- EPS
- PLX N/A
- CLAR 0.13
- Revenue
- PLX $45,667,000.00
- CLAR $269,413,000.00
- Revenue This Year
- PLX N/A
- CLAR N/A
- Revenue Next Year
- PLX $90.00
- CLAR $9.30
- P/E Ratio
- PLX N/A
- CLAR $37.66
- Revenue Growth
- PLX N/A
- CLAR 48.98
- 52 Week Low
- PLX $0.82
- CLAR $3.89
- 52 Week High
- PLX $2.36
- CLAR $7.55
- Technical
- Relative Strength Index (RSI)
- PLX 78.72
- CLAR 56.15
- Support Level
- PLX $2.11
- CLAR $4.30
- Resistance Level
- PLX $2.36
- CLAR $4.65
- Average True Range (ATR)
- PLX 0.12
- CLAR 0.15
- MACD
- PLX 0.00
- CLAR 0.02
- Stochastic Oscillator
- PLX 94.23
- CLAR 82.29
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.